ARWR begins dosing ARO-HBV | ABUS Message Board Posts

Arbutus Biopharma

  ABUS website

ABUS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  34226 of 34737  at  3/27/2018 2:11:02 PM  by

stencil


 In response to msg 34225 by  egomaniakos
view thread

Re: ARWR begins dosing ARO-HBV

Ego,

I have no doubt that Jeffries has a vested interest. No argument. I'm still unclear how reaching P1/2 changes the competitive landscape for ABUS. ARWR cancelled its last program, yet 1 year later they have a new candidate in the clinic, basically at the same stage as ABUS. And they have become a market darling, now trading 1 million+ shares daily, and rewarded with market cap of almost 700 million, almost triple ABUS after years in the clinic. Either ARWR is on to something, or ABUS is on a long road to nowhere. Not sure which. -s


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 253
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
34227 Re: ARWR begins dosing ARO-HBV egomaniakos 7 3/27/2018 2:55:47 PM


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...